This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
India Globalization Capital, Inc. engages in developing and commercializing a portfolio of proprietary cannabinoid based biopharmaceutical therapies for end of life supportive care, hospice care, and chronic neurological and oncological diagnosis.View IGC
India Globalization Capital Inc - IGC - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates India Globalization Capital Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate INDIA GLOBALIZATION CAPITAL (IGC) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself.